Eli Lilly Retatrutide is an investigational drug that is currently being studied for research purposes. Eli Lilly Retatrutide a single molecule that targets three hormone receptors in the body. The three hormone receptors that it targets include glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1), and glucagon receptors. 

Researchers are mainly studying Eli Lilly Retatrutide to explore its potential effects on metabolism, appetite regulation, and body weight.

Currently, Retatrutide is not FDA-approved for human use and can only be studied in lab environments and for research purposes. 

You can buy Retatrutide at Orion Peptides at affordable prices for research purposes. 

Note: The information shared in this blog is only for research purposes. 

Looking for doctor approved medical weight loss? Apply Now

How Much Does Eli Lilly Retatrutide Cost? 

Eli Lilly Retatrutide is not currently available for sale. Researchers are currently studying it in Phase 3 clinical trials. These studies are focused on obesity, type 2 diabetes, knee osteoarthritis pain, obstructive sleep apnea, chronic lower back pain, cardiovascular and kidney health, and metabolic liver disease.

However, if you are interested in Retatrutide research, you can buy it from Orion Peptides. The cost of Retatrutide varies with concentration. Here are the details:

1. Retatrutide 5mg


You can buy Retatrutide 5mg at Orion Peptides for just $64. 

2. Retatrutide 10mg

At Orion Peptides, Retatrutdie 10mg can cost you $95. 

3. Retatrutide 15mg

Retatrutide 15mg can cost you only $140

4. Retarutide 20mg

One vial of Retatrutide 20mg at Orion Peptides can cost up to $172

5. Retatrutide 30mg

Retatrutide 30mg is available at Orion Peptides, costing $390 only.

Note: the FDA does not approve Retatrutide for human use. 

Is Retatrutide Safe to Use Outside Clinical Trials?

Eli Lilly Retatrutide is still an investigational drug. It is only available to people who are part of Eli Lilly and Company clinical trials. The company is still studying its safety and effectiveness.

It has not been approved by any regulatory authority for general public use. Because of this, it should not be used outside of controlled clinical studies.

Lilly also warns people about fake or unverified products being sold online. These may be unsafe and are not real retatrutide.

Is Retatrutide and GLP-3 the Same Thing?

“GLP-3” is not a real scientific term. It is an informal label sometimes used in the media. It is used to describe drugs like Eli Lilly and Company retatrutide.

This nickname comes from the fact that the drug acts on three receptors: GLP-1, GIP, and glucagon. However, “GLP-3” is not an official or accurate classification.

A more correct term is “triple agonist.” This describes how the drug works more clearly and scientifically.

Final Thoughts

Eli Lilly Retatrutide is getting a lot of attention in medical research. It may become an important treatment for obesity and metabolic diseases.

It works in a new way. It targets three hormones at the same time: GLP-1, GIP, and glucagon. Because of this, it is called a triple agonist.

But retatrutide is still not approved for public use. It is still in Phase 3 clinical trials. Researchers are still studying its safety and long-term effects.

Right now, it is not available in pharmacies. It is only used in controlled clinical studies. Any online products claiming to sell it should be treated with caution.

The term “GLP-3” is not correct. It is not a real medical term. People use it informally, but scientists do not use it. The correct term is triple agonist.

In simple words, retatrutide is still in the testing stage. It looks promising, but it is not ready for public use yet. More research is needed before it can be approved.